Currently, Emmanuel Dulac occupies the position of President & Chief Executive Officer at Zealand Pharma A.

He is also on the board of Proteostasis Therapeutics, Inc.

He previously was Vice President-Global Head Lung & Cystic Fibrosis at Novartis AG, Chief Commercial Officer & Senior Vice President at Alnylam Pharmaceuticals, Inc., Associate Director at Sanofi and SVP-Global Head Rare Disease Business Unit at Shire Plc.

Emmanuel Dulac received an MBA from ESSEC Business School and a doctorate from Université Paris-Sud 11.